Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermica Solutions is an international company specializing in the design, development, and manufacture of aesthetic medicine and professional skincare solutions. Headquartered in Spain with a strong presence in Switzerland, the company is recognized for its advanced mesotherapy cocktails and chemical peels. Their product portfolio includes the Dermica Pen, a leading medical device used for microneedling and collagen induction therapy. The company's treatments target a wide range of dermatological concerns, such as skin aging, hyperpigmentation, alopecia, and localized fat. Dermica Solutions places a heavy emphasis on research and development to ensure their products meet high safety and efficacy standards for clinical use. They also provide extensive training and support to aesthetic professionals through the Dermica Academy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermica Solutions.